Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Trial Comparing TAH BSO Versus TAH BSO Plus Adjuvant Pelvic Irradiation in Intermediate Risk Carcinoma of the Endometrium

NCT00002807 is registered in ClinicalTrials.gov with NCIC Clinical Trials Group as lead sponsor.

NCT NCT00002807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Trial Comparing TAH BSO Versus TAH BSO Plus Adjuvant Pelvic Irradiation in Intermediate Risk Carcinoma of the Endometrium
Lead sponsor
NCIC Clinical Trials Group
Phase
Not applicable
Overall status
Completed
Start date
July 4, 1996
Completion date
December 21, 2009
Enrollment
116 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer